tiprankstipranks
Iovance Biotherapeutics (IOVA)
:IOVA
US Market

Iovance Biotherapeutics (IOVA) Cash flow

Compare
3,255 Followers

Iovance Biotherapeutics Cash Flow

IOVA's free cash flow for Q4 2024 was $-77.46M. For the 2024 fiscal year, IOVA's free cash flow was decreased by $20.06M and operating cash flow was $-73.30M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ -352.98M$ -361.82M$ -292.76M$ -227.94M$ -205.13M
Investing Cash Flow
$ -96.41M$ -155.24M$ 256.45M$ 132.00K$ -317.85M
Financing Cash Flow
$ 390.66M$ 462.96M$ 190.15M$ 239.27M$ 576.42M
End Cash Position
$ 122.05M$ 181.32M$ 238.16M$ 84.31M$ 72.85M
Free Cash Flow
$ -364.05M$ -384.11M$ -313.18M$ -265.51M$ -251.93M
Currency in USD

Iovance Biotherapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis